SHA; Deyou

Patent Applications and Registrations

Patent applications and USPTO patent grants for SHA; Deyou.The latest application filed is for "inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflammation, neurodegeneration diseases and diabetes".

Company Profile

3.12.16

SHA; Deyou - Yardley PA
Sha; Deyou - Yardely PA
Sha; Deyou - Yardey PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibitors Of Histone Deacetylase-3 Useful For The Treatment Of Cancer, Inflammation, Neurodegeneration Diseases And Diabetes App 20220177465 - LIU; Jian ; et al.	2022-06-09
Pyrimidone Derivatives As Selective Cytotoxic Agents Against Hiv Infected Cells App 20220064147 - Converso; Antonella ; et al.	2022-03-03
Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases Grant 10,646,494 - Yu , et al.	2020-05-12
Heterocycle-substituted Tetracyclic Compounds And Methods Of Use Thereof For The Treatment Of Viral Diseases App 20190175602 - Yu; Wensheng ; et al.	2019-06-13
Factor XIa inhibitors Grant 10,093,683 - Lim , et al. October 9, 2	2018-10-09
Preparation and use of 3-pyridyl substituted-6,6-difluoro bicyclic himbacine derivatives as par-1 receptor antagonists Grant 9,808,473 - Dropinski , et al. November 7, 2	2017-11-07
FACTOR XIa INHIBITORS App 20170044183 - Lim; Yeon-Hee ; et al.	2017-02-16
Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases Grant 9,555,038 - Yu , et al. January 31, 2	2017-01-31
Preparation And Use Of 3-pyridyl Substituted- 6,6-difluoro Bicyclic Himbacine Derivatives As Par-1 Receptor Antagonists App 20160200713 - Dropinski; James Francis ; et al.	2016-07-14
Cyclic amine substituted heterocyclic CETP inhibitors Grant 9,353,101 - Acton, III , et al. May 31, 2	2016-05-31
Fused bicyclic oxazolidinone CETP inhibitor Grant 9,346,825 - Shao , et al. May 24, 2	2016-05-24
Heterocycle-substituted Tetracyclic Compounds And Methods Of Use Thereof For The Treatment Of Viral Diseases App 20150335648 - Yu; Wensheng ; et al.	2015-11-26
Cyclic Amine Substituted Heterocyclic Cetp Inhibitors App 20150111866 - Acton, III; John J. ; et al.	2015-04-23
4-phenylsulfonamidopiperidines as calcium channel blockers Grant 9,000,174 - Benjamin , et al. April 7, 2	2015-04-07
Fused Bicyclic Oxazolidinone CETP Inhibitor App 20140378493 - Shao; Pengcheng Patrick ; et al.	2014-12-25
Fused bicyclic oxazolidinone CETP inhibitor Grant 8,871,738 - Shao , et al. October 28, 2	2014-10-28
Fused Bicyclic Oxazolidinone Cetp Inhibitor App 20130109649 - Shao; Pengcheng Patrick ; et al.	2013-05-02
Pyrrolidine derived beta 3 adrenergic receptor agonists Grant 8,354,403 - Edmondson , et al. January 15, 2	2013-01-15
Novel Pyrrolidine Derived Beta 3 Adrenergic Receptor Agonists App 20120157432 - Edmondson; Scott D. ; et al.	2012-06-21
Benzenesulfonamide Compounds and Their Use as Blockers of Calcium Channels App 20100022595 - Chen; Zhengming ; et al.	2010-01-28
4-phenylsulfonamidopiperidines as calcium channel blockers App 20090105249 - Benjamin; Elfrida R. ; et al.	2009-04-23
1- Aryl-3-thioalkyl pyrazoles, the synthesis thereof and the use thereof as insecticides Grant 6,518,266 - Dhanoa , et al. February 11, 2	2003-02-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.